Skip to main content
Top
Published in: Clinical Rheumatology 1/2019

01-01-2019 | Brief Report

Non-albumin proteinuria as a parameter of tubulointerstitial inflammation in lupus nephritis

Published in: Clinical Rheumatology | Issue 1/2019

Login to get access

Abstract

Tubulointerstitial inflammation (TI) has prognostic significance in the renal outcomes of lupus nephritis. Here, we aimed to determine whether non-albumin proteinuria is associated with TI severity and with the renal response in lupus nephritis. We included patients with biopsy-confirmed lupus nephritis at a tertiary medical center in Korea from January 2011 to April 2017. Patients in whom the urine protein/creatinine ratio (uPCR) and the urine albumin/creatinine ratio (uACR) were measured simultaneously were included. Laboratory data and renal pathology were reviewed. Non-albumin proteinuria was calculated by subtracting uACR from uPCR. The renal response was assessed by the amount of proteinuria present at 6 months after treatment with immunosuppressants. Logistic regression analyses were performed to identify factors associated with TI severity and renal response. Out of 45 patients, 36 (80%) had no-to-mild TI, whereas 9 (20%) had moderate-to-severe TI. Proliferative (class III ± V/IV ± V) and nonproliferative (class II/V) glomerulonephritis (GN) were present in 38 (84.4%) and 7 (15.6%) patients, respectively. In the logistic regression analyses, non-albumin proteinuria (uPCR − uACR) was associated with moderate-to-severe TI (odds ratio [OR] 3.166, 95% confidence interval [95% CI] 1.145–8.757, p = 0.026) and was inversely associated with complete renal response (adjusted OR 0.180, 95% CI 0.045–0.718, p = 0.015). In lupus nephritis, non-albumin proteinuria was associated with TI severity and with poor renal response after immunosuppressive treatment. Thus, the determination of non-albumin proteinuria can provide clinically valuable information on lupus nephritis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250CrossRefPubMed Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15:241–250CrossRefPubMed
2.
go back to reference Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK, Qu Z, Chen MH, Gao JJ, Li ZY, Zheng X, Ao J, Zhu SN, Wang SX, Zhao MH, Zou WZ, Liu G (2010) Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 77:820–829CrossRefPubMed Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK, Qu Z, Chen MH, Gao JJ, Li ZY, Zheng X, Ao J, Zhu SN, Wang SX, Zhao MH, Zou WZ, Liu G (2010) Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 77:820–829CrossRefPubMed
3.
go back to reference Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR (2011) Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res 63:865–874CrossRef Hsieh C, Chang A, Brandt D, Guttikonda R, Utset TO, Clark MR (2011) Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res 63:865–874CrossRef
4.
go back to reference Pagni F, Galimberti S, Galbiati E, Rebora P, Pietropaolo V, Pieruzzi F, Smith AJ, Ferrario F (2016) Tubulointerstitial lesions in lupus nephritis: international multicentre study in a large cohort of patients with repeat biopsy. Nephrology (Carlton) 21:35–45CrossRef Pagni F, Galimberti S, Galbiati E, Rebora P, Pietropaolo V, Pieruzzi F, Smith AJ, Ferrario F (2016) Tubulointerstitial lesions in lupus nephritis: international multicentre study in a large cohort of patients with repeat biopsy. Nephrology (Carlton) 21:35–45CrossRef
5.
go back to reference Alsuwaida AO (2013) Interstitial inflammation and long-term renal outcomes in lupus nephritis. Lupus 22:1446–1454CrossRefPubMed Alsuwaida AO (2013) Interstitial inflammation and long-term renal outcomes in lupus nephritis. Lupus 22:1446–1454CrossRefPubMed
6.
go back to reference Hebert LA, Parikh S, Prosek J, Nadasdy T, Rovin BH (2013) Differential diagnosis of glomerular disease: a systematic and inclusive approach. Am J Nephrol 38:253–266CrossRefPubMed Hebert LA, Parikh S, Prosek J, Nadasdy T, Rovin BH (2013) Differential diagnosis of glomerular disease: a systematic and inclusive approach. Am J Nephrol 38:253–266CrossRefPubMed
7.
go back to reference Norden AG, Lapsley M, Lee PJ, Pusey CD, Scheinman SJ, Tam FW et al (2001) Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int 60:1885–1892CrossRefPubMed Norden AG, Lapsley M, Lee PJ, Pusey CD, Scheinman SJ, Tam FW et al (2001) Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int 60:1885–1892CrossRefPubMed
8.
go back to reference Nielsen R, Christensen EI (2010) Proteinuria and events beyond the slit. Pediatr Nephrol 25:813–822CrossRefPubMed Nielsen R, Christensen EI (2010) Proteinuria and events beyond the slit. Pediatr Nephrol 25:813–822CrossRefPubMed
9.
go back to reference Smith ER, Cai MM, McMahon LP, Wright DA, Holt SG (2012) The value of simultaneous measurements of urinary albumin and total protein in proteinuric patients. Nephrol Dial Transplant 27:1534–1541CrossRefPubMed Smith ER, Cai MM, McMahon LP, Wright DA, Holt SG (2012) The value of simultaneous measurements of urinary albumin and total protein in proteinuric patients. Nephrol Dial Transplant 27:1534–1541CrossRefPubMed
10.
go back to reference Samarawickrama A, Cai M, Smith ER, Nambiar K, Sabin C, Fisher M, Gilleece Y, Holt SG (2012) Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria. HIV Med 13:526–532PubMed Samarawickrama A, Cai M, Smith ER, Nambiar K, Sabin C, Fisher M, Gilleece Y, Holt SG (2012) Simultaneous measurement of urinary albumin and total protein may facilitate decision-making in HIV-infected patients with proteinuria. HIV Med 13:526–532PubMed
11.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed
12.
go back to reference Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH et al (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75:382–391CrossRefPubMed Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH et al (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75:382–391CrossRefPubMed
13.
go back to reference Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven R, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT, European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (2012) Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71:1771–1782CrossRefPubMedPubMedCentral Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven R, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT, European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (2012) Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71:1771–1782CrossRefPubMedPubMedCentral
14.
go back to reference Chang A, Henderson SG, Brandt D, Liu N, Guttikonda R, Hsieh C, Kaverina N, Utset TO, Meehan SM, Quigg RJ, Meffre E, Clark MR (2011) In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J Immunol 186:1849–1860CrossRefPubMed Chang A, Henderson SG, Brandt D, Liu N, Guttikonda R, Hsieh C, Kaverina N, Utset TO, Meehan SM, Quigg RJ, Meffre E, Clark MR (2011) In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J Immunol 186:1849–1860CrossRefPubMed
15.
go back to reference Steinmetz OM, Velden J, Kneissler U, Marx M, Klein A, Helmchen U, Stahl RAK, Panzer U (2008) Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int 74:448–457CrossRefPubMed Steinmetz OM, Velden J, Kneissler U, Marx M, Klein A, Helmchen U, Stahl RAK, Panzer U (2008) Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int 74:448–457CrossRefPubMed
16.
go back to reference Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D (2011) Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide. Arthritis Care Res 63:351–357 Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D (2011) Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide. Arthritis Care Res 63:351–357
17.
go back to reference Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG et al (2004) Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum 50:3934–3940CrossRefPubMed Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG et al (2004) Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum 50:3934–3940CrossRefPubMed
18.
go back to reference Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS et al (2006) Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med 119:355.e325–355.e333CrossRef Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS et al (2006) Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med 119:355.e325–355.e333CrossRef
Metadata
Title
Non-albumin proteinuria as a parameter of tubulointerstitial inflammation in lupus nephritis
Publication date
01-01-2019
Published in
Clinical Rheumatology / Issue 1/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4256-2

Other articles of this Issue 1/2019

Clinical Rheumatology 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.